✦ LIBER ✦

Experience of recombinant activated factor VII (NovoSeven®) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients

✍ Scribed by Michael Felfernig; Michael Huepfl

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Administration of recombinant activated

✍ Walter E. Uber; John M. Toole; Martha R. Stroud; Jason S. Haney; John Lazarchick 📂 Article 📅 2011 🏛 CTSNet 🌐 English ⚖ 383 KB

Cost effectiveness of recombinant activa

✍ S. Morris; S. Ridley; V. Munro; M. C. Christensen; the NovoSeven® Trauma Study G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Consensus protocol for the use of recomb

✍ P. L. F. GIANGRANDE; J. T. WILDE; B. MADAN; C. A. LUDLAM; E. G. D. TUDDENHAM; N. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Experience with a single dose of recombi

✍ D. ALMAGRO; O. AGRAMONTE; D. CASTILLO; Y. ZAMORA; J. M. BALLESTER 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Cost-Effectiveness of Recombinant Activa

✍ Rolf Rossaint; Michael C. Christensen; Philip Iau Tsau Choong; Kenneth D. Boffar 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 367 KB

Recombinant Activated Factor VII (rFVIIa

✍ Rafael Romero-Castro; Francisco Pellicer-Bautista; Manuel Jiménez-Sáenz; Manuel 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 46 KB